We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: Xianyang, Shaanxi Province, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 1000kg/month
Packaging Information: Double plastic bag inside, aluminum foil bag or fiber drum outside
Delivery Lead Time: in 7 days
Sample Provided: yes
Payment Terms: T/T, Paypal, L/C
Inositol Hexanicotinate 99%
Type
Inositol Hexanicotinate Powder
Form
Powder
Extraction Type
Solvent Extraction
Packaging
Drum, Plastic Container
Place of Origin
China
Shaanxi
Grade
Food Grade
Brand Name
QYHerb
Model Number
Inositol
Application
Health Food
ODM/OEM
Yes
Product Name
Inositol Hexanicotinate Powder
Appearance
White Powder
Specification
99% Purity
Certificate
ISO9001/Halal/Kosher/GMP
Shelf Life
2 Years
MOQ
1kg
Storage
Cool Dried Storage
Sample
Avaliable
Package
1kg/ Bag 25kg/drum
Source
100% Natural Raw Material
Function & Application
Inositol nicotinate has the effect of lowering cholesterol and dilating peripheral blood vessels. It is used for hypercholesterolemia and atherosclerosis. Clinically, it is used for the adjuvant treatment of hyperlipidemia, coronary heart disease, all kinds of peripheral vascular disorders (such as obliterative arteriosclerosis, acro-arterial spasm, frostbite, vascular migraine, etc.).
Seven years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
